Free Trial

American Century Companies Inc. Has $5.68 Million Stock Holdings in Nu Skin Enterprises, Inc. (NYSE:NUS)

Nu Skin Enterprises logo with Consumer Staples background

American Century Companies Inc. lifted its stake in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 12.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 824,739 shares of the company's stock after acquiring an additional 88,181 shares during the quarter. American Century Companies Inc. owned approximately 1.66% of Nu Skin Enterprises worth $5,682,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in NUS. Intech Investment Management LLC bought a new stake in Nu Skin Enterprises in the third quarter worth $138,000. BNP Paribas Financial Markets lifted its position in shares of Nu Skin Enterprises by 69.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 143,319 shares of the company's stock worth $1,056,000 after acquiring an additional 58,880 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Nu Skin Enterprises by 3.7% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 116,424 shares of the company's stock worth $858,000 after buying an additional 4,125 shares in the last quarter. Verition Fund Management LLC bought a new stake in Nu Skin Enterprises in the third quarter valued at about $581,000. Finally, Paloma Partners Management Co acquired a new position in shares of Nu Skin Enterprises in the 3rd quarter worth approximately $273,000. 82.84% of the stock is owned by hedge funds and other institutional investors.

Nu Skin Enterprises Trading Up 5.3 %

Shares of NUS traded up $0.32 during trading hours on Wednesday, reaching $6.34. The stock had a trading volume of 784,595 shares, compared to its average volume of 828,900. Nu Skin Enterprises, Inc. has a 52 week low of $5.92 and a 52 week high of $14.00. The company has a quick ratio of 1.17, a current ratio of 1.82 and a debt-to-equity ratio of 0.56. The company has a market cap of $315.24 million, a P/E ratio of -2.15 and a beta of 1.10. The firm has a 50-day moving average of $7.29 and a 200 day moving average of $7.04.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last announced its earnings results on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. The firm had revenue of $445.55 million during the quarter, compared to analyst estimates of $441.10 million. On average, sell-side analysts expect that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.

Nu Skin Enterprises Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 5th. Shareholders of record on Monday, February 24th were paid a $0.06 dividend. The ex-dividend date was Monday, February 24th. This represents a $0.24 dividend on an annualized basis and a yield of 3.79%. Nu Skin Enterprises's dividend payout ratio is -8.14%.

Analyst Upgrades and Downgrades

NUS has been the subject of several analyst reports. DA Davidson cut their price target on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a "neutral" rating for the company in a report on Friday, December 20th. StockNews.com downgraded shares of Nu Skin Enterprises from a "buy" rating to a "hold" rating in a research note on Tuesday.

Read Our Latest Analysis on NUS

Nu Skin Enterprises Company Profile

(Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Recommended Stories

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Should You Invest $1,000 in Nu Skin Enterprises Right Now?

Before you consider Nu Skin Enterprises, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.

While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines